CHARACTERISTICS OF OLOKIZUMAB PHARMACOKINETICS IN PATIENTS WITH NOVEL CORONAVIRUS INFECTION COVID-19

• Main Authors: E. V. Tavlueva (Author), E. V. Zernova (Author), M. P. Kutepova (Author), N. E. Kostina (Author), V. S. Lesina (Author), D. R. Mould (Author), K. Ito (Author), A. V. Zinchenko (Author), A. N. Dolgorukova (Author), M. V. Nikolskaya (Author), M. S. Lemak (Author), O. V. Filon (Author), M. Yu. Samsonov (Author)
• Format: Book
• Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The aim of the article is to study pharmacokinetic characteristics of intravenous olokizumab in patients with moderate COVID-19 to relieve a hyperinflammation syndrome.Materials and methods. The pharmacokinetic study was conducted as a part of a phase III clinical study (RESET, NCT05187793) on the e...